1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. EXELIXIS INC
Exelixis Inc XNAS: EXEL

Exelixis Inc Live Stock Price Today, Share Analysis and Chart

Mid-range Performer
about

Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and f...

Read More
41.75 0.46 (1.11%)
28.94% Gain from 52W Low
2.3M
XNAS Volume

XNAS 11 Mar, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert
Board Meeting
The board meeting for Exelixis Inc is scheduled for today, for the purpose of 2026 Citizens Life Sciences Conference See details
Durability score
Medium Financial Strength
50.0 / 100
Valuation Score
Mid Valuation
49.8 / 100
Momentum Score
Technically Neutral
47.0 / 100
Mid-range Performer These stocks have average quality, financial and technical momentum, indicating a mid range performer View Similar Embed DVM
Analyst Price Target
47
1Yr Price target upside is 12%
18 analysts

14

S

3

W

6

O

0

T

SWOT Analysis

Exelixis Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..